Parent and group
- Sukhino100%
- Colruyt Group100%
- KORYS66.52%
APOTHEEK BEAUJEAN CENTRUM
ActiveSummary
APOTHEEK BEAUJEAN CENTRUM has been active since 1977 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €346,449 and a net result of €132,957. Equity has been stable since 2019 (±2.4% per year). Its solvency ranks better than 39% of 644 sector peers (NACE 47, financial year 2026). The computed 12-month bankruptcy probability is 0.8% (low).
Overview
Official details
Source: KBO- Status
- Active since 01-07-1977 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 31-03-2026
- Establishment unit
- 2.017.326.222 1500 Halle, since 04-07-1977
- Financial year end
- 31 March
- Peppol
- Reachable since 04-09-2025
Board and ownership
Board
- GJ Lifescience management SRLDirector · since 07-01-2025
- Jo WILLEMYNSDirector · since 07-01-2025
- Kris CASTELEINDirector · since 07-01-2025
Shareholders
- NEWPHARMA GROUP100%· score 8631-03-2026 annual accounts of NEWPHARMA GROUP
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.8%
Annual accounts to 31-03-2026
- Gross margin
- €603,478
- Turnover
- ≈ €2.2m
- estimated
- Profit
- €132,957
- Equity
- €346,449
- Total assets
- €1.5m
- Employees on 31-03-2026
- 5
Score breakdownraises riskLiquidity: current ratio 0.63, cash €11,905, halvedEquity €346,449 (22.5% of total assets)Sector: Retail trade (NACE 47)lowers riskFounded in 1977Show the evidence
Checked score
Score 2026
67
/ 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially stronger than 40% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Average
Solvency
48-25
equity 22.5% of total assets
Liquidity
9-58
short-term debt 76.7% · cash 0.8%
Profitability
80-9
return on assets 8.6%
Bankruptcy probability within 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024lowest value
02-2025: 0.1%● unchanged vs 01-2025lowest value
03-2025: 0.1%● unchanged vs 02-2025lowest value
04-2025: 0.1%● unchanged vs 03-2025lowest value
05-2025: 0.1%● unchanged vs 04-2025lowest value
06-2025: 0.1%● unchanged vs 05-2025lowest value
07-2025: 0.1%● unchanged vs 06-2025lowest value
08-2025: 0.1%● unchanged vs 07-2025lowest value
09-2025: 0.1%● unchanged vs 08-2025lowest value
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.2%▲ +0.1 percentage points vs 01-2026
03-2026: 0.2%● unchanged vs 02-2026
04-2026: 0.4%▲ +0.2 percentage points vs 03-2026
05-2026: 0.4%● unchanged vs 04-2026
06-2026: 0.6%▲ +0.2 percentage points vs 05-2026
07-2026: 1.3%▲ +0.7 percentage points vs 06-2026
08-2026: 1.3%● unchanged vs 07-2026
09-2026: 1.4%▲ +0.1 percentage points vs 08-2026highest value
10-2026: 0.8%▼ -0.6 percentage points vs 09-2026
11-2026: 0.8%● unchanged vs 10-2026
Credit of up to €23,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.63 (1.82 in 2024), below 1. Short-term debt is 76.7% and cash 0.8% of total assets. 77.5% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 38% of them on solvency, 10% on liquidity and 70% on profitability.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2026Equity per financial year
19202122232426
2019 to 2026 · latest year €346,449
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 21-09-2026, 40 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2026
40 days early
2024
45 days early
2023
107 days early
2022
5 days early
2021
3 days early
2020
2 days early
2019
1 day early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 29 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (1)
Key points
Recent changes
- · Gazette deed Permanent representative: VAN CALLEMON EmiliePower of attorney: DEKREM Lowie · Power of attorney: JACQUEMIN Juna
- · Gazette deed 7 directors appointed, 1 director resigningResignation: EMSOFI BV (director) · Permanent representatives: Emmanuel BEAUJEAN, Stefan GOETHAERT and Gilles JOURQUIN · Appointments: Kris CASTELEIN, Peter VANBELLINGEN and 5 others
Companies linked to APOTHEEK BEAUJEAN CENTRUM
Comparable companies
These companies have the same main activity as APOTHEEK BEAUJEAN CENTRUM: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.4m and €1.7m, founded between 1968 and 1987.
| Company | Total assets | Gross margin |
|---|---|---|
| APOTHEEK BEAUJEAN CENTRUM Halle | €1.5m | €0.6m |
| APOTHEEK ANDRÉ DUMONT Maasmechelen | €1.7m | €0.5m |
| Pharmacie Garin Jodoigne | €1.4m | €0.7m |
| PHARMACIE DE LA PORTE DE GHLIN Mons | €1.6m | €0.6m |
| APOTHEEK COPPIN Oostende | €1.4m | €0.6m |
| Pharmacie BOLLY Welkenraedt | €1.5m | €0.7m |
| PHARMACIE MERCURE Jette | €1.4m | €0.5m |
Key facts about APOTHEEK BEAUJEAN CENTRUM
- What is the company number of APOTHEEK BEAUJEAN CENTRUM?
- The company number of APOTHEEK BEAUJEAN CENTRUM is 0417.394.958. The VAT number is the same number with BE in front: BE 0417.394.958.
- Where is APOTHEEK BEAUJEAN CENTRUM based?
- The registered office is at Ninoofsesteenweg 30, 1500 Halle.Company details
- What does APOTHEEK BEAUJEAN CENTRUM do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK BEAUJEAN CENTRUM?
- The legal form of APOTHEEK BEAUJEAN CENTRUM is Private limited company (BV).
- When was APOTHEEK BEAUJEAN CENTRUM founded?
- APOTHEEK BEAUJEAN CENTRUM was founded on 01-07-1977.
- Is APOTHEEK BEAUJEAN CENTRUM still active?
- Yes, APOTHEEK BEAUJEAN CENTRUM is an active enterprise in the KBO register.
- How many employees does APOTHEEK BEAUJEAN CENTRUM have?
- APOTHEEK BEAUJEAN CENTRUM had an average of 4.5 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
- Which joint committee does APOTHEEK BEAUJEAN CENTRUM fall under?
- In its 31-03-2026 annual accounts, APOTHEEK BEAUJEAN CENTRUM states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of APOTHEEK BEAUJEAN CENTRUM?
- The turnover in financial year 2026 is ≈ €2.2m. This figure is estimated from the gross margin of €603,478 and 47 comparable companies (NACE 477). It probably lies between €1.7m and €3.6m.
- Is APOTHEEK BEAUJEAN CENTRUM profitable?
- In financial year 2026, APOTHEEK BEAUJEAN CENTRUM made a profit of €132,957.
- Where can I find the annual accounts of APOTHEEK BEAUJEAN CENTRUM?
- APOTHEEK BEAUJEAN CENTRUM filed 48 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See the other companies in the same group.KORYS · 179 companies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.